Skip to content

Safety and efficacy of IQQA liver three dimensional analysis system in ERCP drainage of hilar cholangiocarcinoma: a randomized controlled clinical trial

Safety and efficacy of IQQA liver three dimensional analysis system in ERCP drainage of hilar cholangiocarcinoma: a randomized controlled clinical trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039942
Enrollment
Unknown
Registered
2020-11-14
Start date
2020-12-15
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hilar cholangiocarcinoma

Interventions

IQQA-liver group:Preoperative IQQQA-Liver evaluation
control group:Regular assessment

Sponsors

Gulou Hospital Affiliated to Medical College of Nanjing University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients who can sign informed consent and understand the necessity and risk of operation; 2. The patients were 18-90 years old and diagnosed as primary drainage of hilar cholangiocarcinoma according to clinical manifestations and imaging data; 3. Patients with hilar cholangiocarcinoma who need ERCP because of biliary obstruction and severe hyperbilirubinemia (TB > 32 µ mol / L).

Exclusion criteria

Exclusion criteria: 1. Patients with benign stenosis, obstructive jaundice caused by stones and poor coagulation function; 2. Patients with severe septic shock leading to multiple organ failure can not tolerate surgery; 3. Patients with poor cooperation, unable to cooperate or refused to accept surgical treatment; 4. Patients with bismuth type I and poor drainage effect at the end of the disease; 5. Patients with obstructive jaundice caused by metastasis and compression of distal cholangiocarcinoma and other malignant tumors.

Design outcomes

Primary

MeasureTime frame
Liver function;

Secondary

MeasureTime frame
Serum amylase;Routine blood;

Countries

China

Contacts

Public ContactZou Xiaoping

Gulou Hospital Affiliated to Medical College of Nanjing University

glyyzxp@163.com+86 25-8310666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026